Breast Surgery Practice Questions

Q: A 21-year-old unmarried woman presents with premenstrual breast fullness and pain. What is the most likely diagnosis?

Fibroadenosis. **Explanation:** **1. Why Fibroadenosis is the Correct Answer:** Fibroadenosis (also known as **Fibrocystic Change** or ANDI - Aberrations of Normal Development and Involution) is the most common cause of breast symptoms in young women. The hallmark of this condition is **cyclical mastalgia** (breast pain) and **premenstrual fullness/heaviness**. It is driven by an exaggerated response of the breast tissue to hormonal fluctuations (estrogen excess or progesterone deficiency) during the menstrual cycle. Symptoms typically peak just before menstruation and subside once the period begins. **2. Why Other Options are Incorrect:** * **Galactocele:** This is a milk-containing cyst that occurs in **lactating** women or shortly after weaning. It presents as a painless, fluctuant mass, not cyclical pain. * **Fibroadenoma:** Known as the "Breast Mouse," it is a painless, highly mobile, firm, and well-defined lump. While common in this age group, it does not typically present with cyclical premenstrual fullness or pain. * **Mastitis:** This is an inflammatory/infectious condition characterized by acute pain, redness, warmth, and systemic symptoms like fever. It is most commonly associated with breastfeeding (lactational mastitis). **3. Clinical Pearls for NEET-PG:** * **ANDI Classification:** Fibroadenosis is considered a physiological variation (ANDI) rather than a true disease. * **Management:** Reassurance is the first line. For severe pain, evening primrose oil (Gamma-linolenic acid) or Danazol (in refractory cases) may be used. * **Differential:** If the pain is non-cyclical and localized, always rule out a breast abscess or underlying malignancy (though rare in this age group). * **Key Buzzwords:** "Cyclical mastalgia," "Premenstrual heaviness," and "Lumpy-bumpy breast" all point toward Fibroadenosis.

Q: What is the management of cystic sarcoma phylloides in a young female?

Wide excision with a margin. **Explanation:** **Phyllodes Tumor (Cystic Sarcoma Phyllodes)** is a fibroepithelial tumor of the breast that resembles a giant fibroadenoma but carries a risk of malignancy. 1. **Why Option A is Correct:** The standard of care for Phyllodes tumor, regardless of whether it is benign, borderline, or malignant, is **Wide Local Excision (WLE)** with a clear margin of at least **1 cm**. This is because these tumors have a high propensity for local recurrence if the margins are involved. Since Phyllodes tumors spread via the bloodstream (hematogenous) rather than the lymphatic system, routine axillary lymph node dissection is not required. 2. **Why Other Options are Incorrect:** * **B & C (Chemo/Radiotherapy):** Phyllodes tumors are generally resistant to chemotherapy and radiotherapy. These modalities are reserved only for palliative care or rare, recurrent malignant cases; they are not part of the primary management. * **D (Modified Mastectomy):** This is overly aggressive for a young female. Simple mastectomy is only indicated if the tumor is so large that a 1 cm margin cannot be achieved without compromising the cosmetic outcome (tumor-to-breast ratio). **High-Yield Clinical Pearls for NEET-PG:** * **Leaf-like pattern:** The name "Phyllodes" comes from the Greek word for "leaf-like," referring to the characteristic histological appearance of stromal overgrowth. * **Age Group:** Typically presents in women aged 35–50 (older than the typical fibroadenoma age). * **Clinical Feature:** Rapidly enlarging, painless, mobile mass; may cause skin necrosis due to pressure, but rarely involves the nipple-areola complex. * **Metastasis:** If malignant, it most commonly spreads to the **Lungs**. * **Diagnosis:** Triple assessment is key, but Core Needle Biopsy is preferred over FNAC (FNAC cannot reliably distinguish between fibroadenoma and Phyllodes).

Q: Virchow's node is seen in which anatomical location?

Left supraclavicular fossa. **Explanation:** **Virchow’s node** (also known as Troisier’s sign) refers to a palpable, firm, enlarged lymph node in the **left supraclavicular fossa**. **Why the Left Supraclavicular Fossa?** The anatomical basis for this location is the **Thoracic Duct**. The thoracic duct drains lymph from most of the body (abdomen, pelvis, and lower limbs) and ascends to empty into the junction of the left internal jugular and subclavian veins. Malignancies, most commonly **Gastric Adenocarcinoma**, can metastasize via the thoracic duct to these sentinel nodes. The presence of this node often indicates advanced, inoperable intra-abdominal malignancy. **Analysis of Incorrect Options:** * **Anterior mediastinum:** This area contains the thymus and lymph nodes that typically drain the heart, lungs, and thyroid; it is not the site for Virchow’s node. * **Posterior triangle of neck:** While the supraclavicular fossa is technically in the lower part of the neck, Virchow's node is specifically localized to the supraclavicular region (Level Vb) rather than the general posterior triangle. * **Inguinal region:** Enlargement here (e.g., Cloquet’s node) typically indicates pathology in the lower extremities, perineum, or anal canal. **Clinical Pearls for NEET-PG:** * **Troisier’s Sign:** The clinical finding of a palpable Virchow’s node. * **Sister Mary Joseph’s Nodule:** Periumbilical lymphadenopathy associated with metastatic intra-abdominal malignancy. * **Irish’s Node:** Left axillary lymph node enlargement associated with gastric cancer. * **Krukenberg Tumor:** Metastasis of gastric cancer to the ovaries. * **Differential:** While gastric cancer is the classic cause, Virchow’s node can also be seen in cancers of the pancreas, testis, and kidneys.

Q: What is the most common site of bone metastasis?

Carcinoma of the breast. **Explanation:** The correct answer is **Carcinoma of the Breast**. **Why Breast Carcinoma is Correct:** In clinical practice, **Carcinoma of the Breast** is the most common primary malignancy to metastasize to the bone. This is due to its high overall prevalence in the population and its long natural history, which provides a larger window for hematogenous spread. Breast cancer cells have a high affinity for the bone marrow microenvironment (osteotropism), frequently resulting in **mixed lesions** (both osteoblastic and osteolytic). **Analysis of Incorrect Options:** * **Carcinoma of the Prostate:** While this is the most common cause of bone metastasis in **men**, it ranks second to breast cancer when considering the general population. It characteristically produces **osteoblastic** (sclerotic) lesions. * **Carcinoma of the Kidney (RCC):** RCC frequently metastasizes to the bone, but it is less common than breast or prostate. It typically presents as **purely osteolytic**, expansile, and highly vascular ("pulsatile") lesions. * **Carcinoma of the Thyroid:** Specifically follicular thyroid cancer spreads hematogenously to the bone, but its overall incidence is much lower than breast cancer. **NEET-PG High-Yield Pearls:** * **Most common site of bone metastasis:** Spine (specifically the lumbar spine), followed by the pelvis and femur. * **Route of spread:** Most commonly via the **Batson’s venous plexus** (a valveless vertebral venous system), which explains the high frequency of spinal involvement. * **Type of Lesion:** * **Purely Osteolytic:** Kidney, Thyroid, Lung (NSCLC). * **Purely Osteoblastic:** Prostate, Carcinoid, Small cell lung cancer. * **Mixed:** Breast (most common). * **Investigation of Choice:** **99mTc-MDP Bone Scan** is the most sensitive screening tool (except for purely lytic lesions like Multiple Myeloma, where X-rays or MRI are preferred).

Q: Which of the following is NOT true about papillary carcinoma of the breast?

It is typically a large tumor.. **Explanation:** Papillary carcinoma of the breast is a rare subtype of invasive ductal carcinoma, accounting for approximately 1–2% of all breast cancers. **Why Option B is the correct answer (The False Statement):** Contrary to many other invasive breast malignancies, papillary carcinoma is typically a **small tumor**, often measuring less than 2–3 cm at the time of diagnosis. While it can occasionally present as a large cystic mass (intracystic papillary carcinoma), the classic invasive form is characterized by its small size and slow growth rate. **Analysis of other options:** * **Option A (True):** This carcinoma predominantly affects postmenopausal women, with a peak incidence in the **seventh decade** (60–70 years). This is older than the average age for standard infiltrating ductal carcinoma (NOS). * **Option C (True):** One of the hallmark features of papillary carcinoma is its **indolent nature**. It has a significantly lower frequency of axillary lymph node involvement compared to other invasive types, contributing to its excellent overall prognosis. **NEET-PG High-Yield Pearls:** * **Clinical Presentation:** Often presents as a subareolar mass; may be associated with bloody nipple discharge (though more common in benign intraductal papillomas). * **Histology:** Characterized by finger-like projections (papillae) with fibrovascular cores lined by epithelial cells. A key diagnostic feature is the **absence of a myoepithelial layer** within the papillae. * **Prognosis:** It carries one of the best prognoses among breast cancers, with a 10-year survival rate exceeding 90%. * **Triple Negative Status:** It is frequently Estrogen Receptor (ER) and Progesterone Receptor (PR) positive, further contributing to its favorable outcome.

Q: Which structures are preserved in a Modified radical mastectomy?

All of the above. In **Modified Radical Mastectomy (MRM)**, the goal is to remove the entire breast tissue along with the axillary lymph nodes (Levels I and II) while preserving specific vital structures to maintain function and reduce morbidity. This distinguishes it from the Halsted Radical Mastectomy, which is now largely obsolete. **Explanation of Options:** * **Pectoralis major muscle (Option B):** In MRM (specifically the Patey or Auchincloss modifications), the pectoralis major is preserved. This maintains the chest wall contour and provides a muscular base for future breast reconstruction. * **Axillary vein (Option A):** This is the superior boundary of the axillary dissection. It must be preserved to ensure venous drainage of the upper limb; accidental ligation leads to severe lymphedema. * **Nerves to serratus anterior (Option C):** Also known as the **Long Thoracic Nerve of Bell**. Preserving this nerve is crucial to prevent "Winging of the Scapula." **High-Yield Clinical Pearls for NEET-PG:** 1. **Nerves to preserve:** * **Long Thoracic Nerve:** Supplies Serratus Anterior (Injury = Winging of Scapula). * **Thoracodorsal Nerve:** Supplies Latissimus Dorsi (Injury = Weakness in internal rotation/adduction). 2. **Nerve often sacrificed:** The **Intercostobrachial nerve** is frequently cut, leading to numbness in the skin of the medial aspect of the upper arm. 3. **Modifications:** * **Auchincloss:** Preserves both Pectoralis major and minor. * **Patey:** Preserves Pectoralis major but removes Pectoralis minor to access Level III nodes. 4. **Boundaries of Axillary Dissection:** Axillary vein (superior), Latissimus dorsi (lateral), and Serratus anterior (medial).

Q: What is true about the lymphatic spread of breast cancer?

All of the above.. The lymphatic drainage of the breast is a critical concept in surgical oncology, as it dictates the staging and surgical management of breast cancer. **Explanation of the Correct Answer:** The correct answer is **D (All of the above)** because breast cancer follows predictable yet multi-directional lymphatic pathways: * **Option A:** Approximately **75% of the lymph** from the breast drains into the **axillary lymph nodes**. Consequently, they are the most common site of regional metastasis. * **Option B:** The remaining **25% of lymph** (primarily from the medial and deep quadrants) drains into the **internal mammary lymph nodes** located along the sternal border. Involvement here is significant for prognosis and radiotherapy planning. * **Option C:** Lymphatic spread to the **supraclavicular nodes** usually occurs after the involvement of axillary nodes (Level III) or via the internal mammary chain. This occurs through **lymphatic embolization**, where tumor cells travel as "emboli" through the vessels. **Clinical Pearls for NEET-PG:** * **Berg’s Levels of Axillary Nodes:** Defined by their relation to the **Pectoralis Minor** muscle: * *Level I:* Lateral to the muscle. * *Level II:* Behind the muscle (includes Rotter’s nodes). * *Level III:* Medial/Superior to the muscle. * **Sentinel Lymph Node Biopsy (SLNB):** The gold standard for axillary staging in clinically node-negative (cN0) patients. * **Rotter’s Nodes:** Interpectoral nodes located between the pectoralis major and minor muscles. * **Staging Note:** Involvement of supraclavicular nodes is classified as **N3** (Regional) in the AJCC 8th edition, not distant metastasis (M1).

Question 1

A 21-year-old unmarried woman presents with premenstrual breast fullness and pain. What is the most likely diagnosis?

Accepted Answer

Fibroadenosis

Answer

Galactocele

Answer

Fibroadenoma

Answer

Mastitis

Question 2

A 53-year-old waitress inquires about the implications of positive estrogen receptors (ER+) in an invasive carcinoma that was excised from her left breast. What should she be informed of?

Accepted Answer

Estrogen receptor (ER) and progesterone receptor (PR) status should be determined in all cases of breast carcinoma.

Answer

Positive estrogen receptors are more often found in patients under 50 years of age.

Answer

If the receptors are positive, antiestrogen therapy is not indicated.

Answer

If the receptors are positive, the prognosis is more unfavorable.

Question 3

What is the management of cystic sarcoma phylloides in a young female?

Accepted Answer

Wide excision with a margin

Answer

Wide excision and chemotherapy

Answer

Wide excision and radiotherapy

Answer

Modified mastectomy

Question 4

Virchow's node is seen in which anatomical location?

Accepted Answer

Left supraclavicular fossa

Answer

Anterior mediastinum

Answer

Posterior triangle of neck

Answer

Inguinal region

Question 5

Which of the following is a method for conservative treatment of breast cancer?

Accepted Answer

Treatment is based on the relative size of the breast tumor.

Answer

Radiotherapy is administered.

Answer

Chemotherapy is administered.

Answer

Surgery is considered the best modality of treatment.

Question 6

What is the most common site of bone metastasis?

Accepted Answer

Carcinoma of the breast

Answer

Carcinoma of the kidney

Answer

Carcinoma of the prostate

Answer

Carcinoma of the thyroid

Question 7

Which of the following is NOT true about papillary carcinoma of the breast?

Accepted Answer

It is typically a large tumor.

Answer

It typically presents in the seventh decade of life.

Answer

It has a low frequency of axillary lymph node metastases.

Answer

None of the above.

Question 8

Which of the following are hormonal therapies used in breast cancer?

Accepted Answer

LHRH analogue

Answer

Danazol

Answer

Cyproterone acetate

Answer

Tamoxifen

Question 9

Which structures are preserved in a Modified radical mastectomy?

Accepted Answer

All of the above

Answer

Axillary vein

Answer

Pectoralis major muscle

Answer

Nerves to serratus anterior

Question 10

What is true about the lymphatic spread of breast cancer?

Accepted Answer

All of the above.

Answer

Axillary lymph nodes are most commonly involved.

Answer

Internal mammary lymph nodes can also be involved.

Answer

Spread to supraclavicular lymph nodes can occur by lymphatic embolization.

Breast Surgery — MCQs

Breast Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?